Private Capital Management (Minnesota)’s Novartis NVS Stock Holding History

Private Capital Management (Minnesota)’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$386K	Hold	5,022	–	–	0.43%	110
2017 Q2	$376K	Sell	5,022 -3,571	-42%	-$253K	0.42%	111
2017 Q1	$572K	Sell	8,593 -1,451	-14%	-$96.7K	0.63%	56
2016 Q4	$656K	Sell	10,044 -3,125	-24%	-$203K	0.73%	41
2016 Q3	$932K	Hold	13,169	–	–	0.98%	25
2016 Q2	$974K	Sell	13,169 -1,506	-10%	-$104K	0.96%	25
2016 Q1	$952K	Buy	14,675 +5,077	+53%	+$345K	0.87%	27
2015 Q4	$740K	Buy	+9,598	New	+$762K	0.68%	47

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Private Capital Management (Minnesota)'s NVS Position: Q3 2017 in Review

Private Capital Management (Minnesota) held its Novartis (NVS) position steady in Q3 2017 at 5,022 shares worth $386K. The position accounts for 0.43% of the portfolio, ranked #110.

Private Capital Management (Minnesota) first reported a position in NVS in Q4 2015 and has held it in 8 quarters since. The position peaked at $974K in Q2 2016. 938 funds tracked by Wall St. Rank hold NVS as of Q3 2017.

Private Capital Management (Minnesota) held 5,022 shares of Novartis worth $386K as of Q3 2017.
Private Capital Management (Minnesota) left its Novartis share count unchanged in Q3 2017.
Novartis made up 0.43% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #110 holding.
Private Capital Management (Minnesota) first reported a position in Novartis in Q4 2015 and has held it in 8 quarters since.
Private Capital Management (Minnesota)'s Novartis position peaked at $974K in Q2 2016.
938 funds tracked by Wall St. Rank held Novartis as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.